Terada T, Komai N, Hayashi S, Moriwaki H, Hyoutani G, Uematsu Y, Karasawa J, Kikuchi H
Neurosurgery. 1986 Apr;18(4):415-8. doi: 10.1227/00006123-198604000-00004.
Hemorrhagic infarction after vasospasm is a rare condition in patients with aneurysmal subarachnoid hemorrhage (SAH). Induced hypertensive therapy is used for patients with vasospasm, but this treatment has a risk of inducing hemorrhagic infarction. A total of 221 patients whose first computed tomographic (CT) scans were examined within 2 weeks after SAH were investigated for this study. There was symptomatic vasospasm in 99 (45%), cerebral infarction in 37 (17%), and hemorrhagic infarction in 13 (6%). Hemorrhagic infarction usually occurred 20 to 30 days after aneurysmal rupture; this period corresponds with the remission stage of the vasospasm. On CT scans, the hemorrhagic infarction was revealed as a leaky hemorrhage in a low density area in 11 cases, and a massive hemorrhage with mass effect was seen in 2 cases. These findings suggest that hemorrhagic infarction after vasospasm may sometimes be fatal. Cerebral blood flow autoregulation in patients with vasospasm was normal or of a hypertensive type during the remission stage of vasospasm, when hemorrhagic infarction usually appeared. This finding shows that induced hypertension therapy is ineffective during this stage; it should be stopped by this stage because it is ineffective and also may aggravate hemorrhagic infarction.
血管痉挛后出血性梗死在动脉瘤性蛛网膜下腔出血(SAH)患者中是一种罕见情况。诱导性高血压治疗用于血管痉挛患者,但这种治疗有诱发出血性梗死的风险。本研究对221例在SAH后2周内进行首次计算机断层扫描(CT)的患者进行了调查。99例(45%)有症状性血管痉挛,37例(17%)有脑梗死,13例(6%)有出血性梗死。出血性梗死通常发生在动脉瘤破裂后20至30天;这一时期与血管痉挛的缓解期相对应。在CT扫描上,11例出血性梗死表现为低密度区内的渗漏性出血,2例可见有占位效应的大量出血。这些发现提示血管痉挛后出血性梗死有时可能是致命的。在通常出现出血性梗死的血管痉挛缓解期,血管痉挛患者的脑血流自动调节功能正常或呈高血压型。这一发现表明在此阶段诱导性高血压治疗无效;应在此阶段停止该治疗,因为它无效且还可能加重出血性梗死。